Optimizing use of revascularization and clinical outcomes in ST-elevation myocardial infarction: Insights from the GUSTO-V trial

European Heart Journal

Volumn 27, Issue 10, 2006, Pages 1198-1206

  Kaul, Padma ^a   Chang, Wei Ching ^a   Lincoff, A Michael ^b   Aylward, Philip ^c   Betriu, Amadeo ^d   Bode, Christoph ^e   Califf, Robert M ^f   Ohman, E Magnus ^g   Guetta, Victor ^h   Steg, P Gabriel ⁱ   Van De Werf, Frans ^j   Armstrong, Paul W ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b LERNER RESEARCH INSTITUTE   (United States)

^c FLINDERS MEDICAL CENTRE   (Australia)

^d Institut De Malaties Digestives   (Spain)

^e UNIVERSITY OF FREIBURG   (Germany)

^f DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^g UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

^h Hospital Bichat ^*

ⁱ BICHAT HOSPITAL   (France)

^j Gasthuisberg University Hospital   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; RETEPLASE;

ARTICLE; AUSTRALIA; BELGIUM; CANADA; CLINICAL STUDY; CLINICAL TRIAL; DEMOGRAPHY; FIBRINOLYTIC THERAPY; FINLAND; FRANCE; GERMANY; HEALTH CARE DELIVERY; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; ITALY; MORTALITY; NETHERLANDS; NORWAY; OUTCOME VARIABLE; POLAND; PRIORITY JOURNAL; ST SEGMENT ELEVATION; ST SEGMENT ELEVATION HEART INFARCTION; TREATMENT OUTCOME; UNITED KINGDOM; UNITED STATES;

EID: 33646746787     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi854     Document Type: Article

References (24)

1. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC Jr, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, American College of Cardiology, American Heart Association Task Force on Practice Guidelines. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction - executive summary: a report of the American College of Cardiology/American heart association task force on practice guidelines (writing committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). Circulation 2004;110:588-636.
2. Barbash GI, Modan M, Goldbourt U, White HD, Van de Werf F. Comparative case fatality analysis of the international tissue plasminogen Activator/Streptokinase mortality trial: variation by country beyond predictive profile. The investigators of the international tissue plasminogen Activator/Streptokinase mortality trial. J Am Coll Cardiol 1993;21:281-286.
3. Giugliano RP, Llevadot J, Wilcox RG, Gurfinkel EP, McCabe CH, Charlesworth A, Thompson SL, Antman EM, Braunwald E; InTIME (Intravenous nPA for Treatment of Infarcting Myocardium Early)II Investigators. Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis. Results from InTIME-II. Eur Heart J 2001;22:1702-1715.
4. Gupta M, Chang WC, Van de Werf F, Granger CB, Midodzi W, Barbash G, Pehrson K, Oto A, Toutouzas P, Jansky P, Armstrong PW; ASSENT II Investigators. International differences in in-hospital revascularization and outcomes following acute myocardial infarction: a multilevel analysis of patients in ASSENT-2. Eur Heart J 2003;24:1640-1650.
5. Hemingway H, Crook AM, Feder G, Banerjee S, Dawson JR, Magee P, Philpott S, Sanders J, Wood A, Timmis AD. Underuse of coronary revascularization procedures in patients considered appropriate candidates for revascularization. N Engl J Med 2001;344:645-654.
6. Kaul P, Armstrong PW, Chang WC, Naylor CD, Granger CB, Lee KL, Peterson ED, Califf RM, Topol EJ, Mark DB. Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in global utilization of streptokinase and t-PA for occluded coronary arteries (GUSTO)-I. Circulation 2004;110:1754-1760.
7. Mark DB, Hlatky MA. Medical economics and the assessment of value in cardiovascular medicine: Part I. Circulation 2002;106:516-520.
8. Mark DB, Naylor CD, Hlatky MA, Califf RM, Topol EJ, Granger CB, Knight JD, Nelson CL, Lee KL, Clapp-Channing NE. Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. N Engl J Med 1994;331:1130-1135.
9. Martin RM, Hemingway H, Gunnell D, Karsch KR, Baumbach A, Frankel S. Population need for coronary revascularisation: are national targets for England credible? Heart 2002;88:627-633.
10. Rouleau JL, Moye LA, Pfeffer MA, Arnold JM, Bernstein V, Cuddy TE, Dagenais GR, Geltman EM, Goldman S, Gordon D; The SAVE Investigators. A comparison of management patterns after acute myocardial infarction in Canada and the United States. N Engl J Med 1993;328:779-784.
11. Stenestrand U, Wallentin L. Early revascularisation and 1-year survival in 14-day survivors of acute myocardial infarction: a prospective cohort study. Lancet 2002;359:1805-1811.
12. Topol EJ, GUSTO V Investigators. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: The GUSTO V randomized trial. Lancet 2001;357:1905-1914.
13. Tu JV, Pashos CL, Naylor CD, Chen E, Normand SL, Newhouse JP, McNeil BJ. Use of cardiac procedures and outcomes in elderly patients with myocardial infarction in the United states and Canada. N Engl J Med 1997;336:1500-1505.
14. Van de Werf F, Topol EJ, Lee KL, Woodlief LH, Granger CB, Armstrong PW, Barbash GI, Hampton JR, Guerci A, Simes RJ. Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO trial. Global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries. JAMA 1995;273:1586-1591.
15. Woods KL, Ketley D, Agusti A, Hagn C, Kala R, Karatzas NB, Leizorowicz A, Reikvam A, Schilling J, Seabra-Gomes R, Vasiliauskas D, Wilhelmsen L. Use of coronary angiography and revascularization procedures following acute myocardial infarction. A European perspective. Eur Heart J 1998;19:1348-1354.
16. Organization of Economic Co-operation and Development. Percentage Gross Domestic Product Expenditures on Health. 2001; Available at http://www.oecd.org/
17. World Health Organization. Life Expectancy estimates. 2001; Available at http://www.who.int/
18. Avilis FF, Alonso JJ, Castro-Beiras A, Vazquez N, Blanco J, Alonso-Briales J, Lopez-Mesa J, Fernandez-Vazquez F, Calvo I, Martinez-Elbal L. Routine invasive strategy within 24 h of thrombolysis vs ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomized controlled trial. Lancet 2004;364:1045-1053.
19. Le May MR, Wells GA, Labinaz M, Davies RF, Turek M, Leddy D, Maloney J, McKibbin T, Quinn B, Beanlands RS. Combined Angioplasty and Pharmacological Intervention vs Thrombolysis Alone in Acute Myocardial Infarction (CAPITAL AMI trial). J Am Coll Cardiol 2005;46:417-424.
20. Scheller B, Hennen B, Hammer B, Walle J, Hofer C, Hilpert V, Winter H, Nickenig G, Bohm M, for the SIAM III Study Group. Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction. J Am Coll Cardiol 2003;42:634-641.
21. Cantor WJ, Brunet F, Ziegler CP, Kiss A, Morrison LJ. Immediate angioplasty after thrombolysis: a systematic review. CMAJ 2005;173:1473-1481.
22. Assessment of the Safety Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) Investigators. Primary vs tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomized trial. Lancet 2006;367:569-578.
23. Gershlick AH, Stephens-Lloyd A, Hughes S, Abrams KR, Stevens SE, Uren NG, de Belder A, Davis J, Pitt M, Banning A. Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction. N Engl J Med 2005;353:2758-2768.
24. Sutton AGC, Campbell PG, Graham R, Price DJA, Gray JC, Grech ED, Hall JA, Harcombe AA, Wright RA, Smith RH. A randomized trial of rescue angioplasty vs. a conservative approach for failed fibrinolysis in ST-segment elevation myocardial infarction: the Middlesbrough Early Revascularization to Limit Infarction (MERLIN) trial. J Am Coll Cardiol 2004;44:287-296.